United Capital Financial Advisors LLC Invests $3.46 Million in Cigna Group $CI

United Capital Financial Advisors LLC bought a new position in Cigna Group (NYSE:CIFree Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 12,551 shares of the health services provider’s stock, valued at approximately $3,460,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CI. Wilkerson Advisory Group LLC acquired a new position in shares of Cigna Group in the 4th quarter worth $25,000. Osbon Capital Management LLC purchased a new stake in Cigna Group during the second quarter valued at about $26,000. Johnson Financial Group Inc. acquired a new position in shares of Cigna Group in the second quarter worth about $29,000. Kemnay Advisory Services Inc. acquired a new position in shares of Cigna Group in the fourth quarter worth about $29,000. Finally, Prosperity Bancshares Inc purchased a new position in Cigna Group during the 4th quarter worth approximately $29,000. 86.99% of the stock is owned by institutional investors.

Insider Buying and Selling at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

CI has been the topic of several recent analyst reports. Sanford C. Bernstein upped their price target on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Wells Fargo & Company upped their target price on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Finally, Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Check Out Our Latest Stock Analysis on Cigna Group

Cigna Group Trading Up 0.4%

Cigna Group stock opened at $278.89 on Friday. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The company has a market capitalization of $73.69 billion, a price-to-earnings ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company’s fifty day moving average price is $283.52 and its two-hundred day moving average price is $281.39.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the prior year, the firm earned $7.20 EPS. Cigna Group’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is 25.82%.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.